CCME Global Ltd
₹35.24▼ -1.85 (-4.99%)
CCME·BSE·Healthcare
Market Cap
159.46 Cr
PE Ratio
-150.40
Volume
7,755
Day High - Low
38.94 - 35.24
52W High-Low
177.65 - 26.41
₹35.24▼ -1.85 (-4.99%)
Market Cap159.46 Cr
PE Ratio-150.40
Volume7,755
Day High - Low38.94 - 35.24
52W High-Low177.65 - 26.41
CCME Global Ltd (CCME): company summary
The company's business is not generating revenue or profit, with annual revenue and net profit at ₹0 crore and a ₹1 crore loss respectively.
CCME Global Ltd (CCME) is a micro-cap Healthcare company valued at ₹159 crore operating in Biotechnology on the NSE and BSE.
- Recent price move
- CCME Global Ltd last traded at ₹35.24, down 4.99% on the day.
- Recent developments
- 2026-06-30: The company reported a net loss of ₹1 crore for the latest financial year, continuing a trend of widening losses from ₹0 crore to ₹1 crore over three years. 2026-06-30: Promoter holding increased by 0.18 percentage points to 74.35%, signaling continued control by the promoter.
- Financial performance
- The company's business is not generating revenue or profit, with annual revenue and net profit at ₹0 crore and a ₹1 crore loss respectively. The latest quarter shows no change in the net loss, while the annual net profit swung from a ₹4 crore profit to a ₹1 crore loss. Margins and returns are at 0.0% and -1.8%, respectively, indicating no profitability.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 3.23 times book value.
- Things to watch
- The company is reporting a net loss of ₹1 crore, with no revenue generated. Net profit margins are at 0.0%, and returns on equity and capital employed are both -1.8%. The stock is 79.1% below its 52-week high, indicating a significant drop in value.
- Where it stands
- CCME Global Ltd continues to report a net loss of ₹1 crore with no revenue, and the stock is 79.1% below its 52-week high. The promoter holding increased slightly to 74.35%, but the company remains unprofitable and has no recent revenue.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
1.0/10
Poor
Fair Value
Sign in to see
ROE
-1.78%
Weak
P/E
-150.40x
Loss-making
Debt / Equity
0.00
Low
Industry
Healthcare
Biotechnology
Overall View
Poor
Price performance
Day₹35.24
₹38.94
52W₹26.41
₹177.65
DocStoX take
Held back by momentum (0.0). Scored on 4 of 5 measures.
DocStoX score
Low confidence1.0
/10
Poor
Quality
Weak
ROE -1.8%
Valuation
Rich
P/B 3.2× on assets (no earnings to value)
Growth
No data
No multi-year history
Risk
Moderate
D/E 0.00
Momentum
Weak
6% of 52-week range
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹159 Cr
52W High / Low
₹178 / ₹26
Dividend Yield
0.00%
Promoter Holding
74.35%
EPS (TTM)
₹-0.16
Book Value
₹8.85
Key highlights
- Low leverage — D/E 0.00
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Biotechnology
Explore CCME Global Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
CCME Global Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value CCME Global Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing